Cargando…

Acute Effects of Pimobendan on Cardiac Function in Dogs With Tachycardia Induced Dilated Cardiomyopathy: A Randomized, Placebo-Controlled, Crossover Study

Background: Pimobendan provides a significant survival benefit in dogs with cardiac disease, including degenerative mitral valve disease and dilated cardiomyopathy (DCM). Its positive inotropic effect is well-known, however, it has complex effects and the mechanisms behind the survival benefit are n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbott-Johnson, Kaitlin, Pierce, Kursten V., Roof, Steve, del Rio, Carlos L., Hamlin, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281278/ https://www.ncbi.nlm.nih.gov/pubmed/34277749 http://dx.doi.org/10.3389/fvets.2021.646437

Ejemplares similares

Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study
por: Oldach, Maureen S., et al.
Publicado: (2019)

Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
por: Pichayapaiboon, Poonavit, et al.
Publicado: (2021)

Pharmacokinetics of Pimobendan and Its Metabolite O-Desmethyl-Pimobendan Following Rectal Administration to Healthy Dogs
por: Her, Jiwoong, et al.
Publicado: (2020)

Hemodynamic effect of pimobendan following intramuscular and intravenous administration in healthy dogs: A pilot study
por: Enokizono, Masayuki, et al.
Publicado: (2022)

The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study
por: Klein, Stephanie, et al.
Publicado: (2021)

Risk factors for atrial fibrillation in dogs with dilated cardiomyopathy
por: Guglielmini, Carlo, et al.
Publicado: (2023)

Left ventricular strain distribution in healthy dogs and in dogs with tachycardia-induced dilated cardiomyopathy
por: Kusunose, Kenya, et al.
Publicado: (2013)

Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study)
por: Summerfield, NJ, et al.
Publicado: (2012)

Oligosaccharides and diet-related dilated cardiomyopathy in beagles
por: Bokshowan, Elise, et al.
Publicado: (2023)

Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs
por: Pirintr, Prapawadee, et al.
Publicado: (2023)

Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2020)

Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy
por: Oldach, Maureen S., et al.
Publicado: (2021)

Inotropic effects of a single intravenous recommended dose of pimobendan in healthy dogs
por: HORI, Yasutomo, et al.
Publicado: (2018)

Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
por: McManamey, Anna K., et al.
Publicado: (2023)

Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy
por: Katz, Moshe, et al.
Publicado: (2023)

Long‐term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy
por: Vollmar, A.C., et al.
Publicado: (2016)

Thyroid Storm-induced Severe Dilated Cardiomyopathy and Ventricular Tachycardia
por: Sourial, Kirolus, et al.
Publicado: (2019)

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study
por: Boswood, A., et al.
Publicado: (2017)

Retrospective study of dilated cardiomyopathy in dogs
por: Freid, Kimberly J., et al.
Publicado: (2020)

Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease
por: Sarcinella, Fabio, et al.
Publicado: (2019)

Preliminary Bioequivalence of an Oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs
por: Saengklub, Nakkawee, et al.
Publicado: (2022)

Haemodynamic Effects of Pimobendan during General Anaesthesia in Healthy Senior Dogs: A Prospective, Randomised, Triple-Blinded, Placebo-Controlled Clinical Study
por: Sández, Ignacio, et al.
Publicado: (2023)

LMNA Gene Mutation Presenting with Ventricular Tachycardia in the Absence of Dilated Cardiomyopathy
por: Poudel, Binod, et al.
Publicado: (2022)

Letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Atkins, Clarke, et al.
Publicado: (2021)

Pimobendan B from powder diffraction data
por: Zvirgzdins, Alvis, et al.
Publicado: (2013)

Repeated-Dose Pharmacodynamics of Pimobendan in Healthy Cats
por: Sugimoto, Keisuke, et al.
Publicado: (2022)

Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial
por: Boswood, A., et al.
Publicado: (2016)

Kinetics of Plasma Cytokines, Angiopoietin-2, and C-Reactive Protein in Dogs With Gastric Dilatation Volvulus
por: Brunner, Anna, et al.
Publicado: (2021)

Bidirectional Ventricular Tachycardia in a Women with Dilated Cardiomyopathy: A Case Report
por: Norwood, Dalton Argean, et al.
Publicado: (2019)

Catecholaminergic polymorphic ventricular tachycardia complicated by dilated cardiomyopathy: a case report
por: Christina, Granitz, et al.
Publicado: (2020)

Concentrations and kinetics of renal biomarkers in dogs with gastric dilatation-volvulus with and without 24-h intravenous lidocaine
por: Lehmann, Anna, et al.
Publicado: (2023)

A randomized crossover study of the effect of butorphanol–lidocaine and tramadol–lidocaine on sevoflurane's minimum alveolar concentration in dogs
por: Marzok, Mohamed, et al.
Publicado: (2023)

Left Atrial Tachycardia and Third-Degree Atrioventricular Block in a Dog
por: Côté, Etienne, et al.
Publicado: (2022)

Effects of pimobendan on left atrial transport function in cats
por: Kochie, Samantha L., et al.
Publicado: (2020)

Erratum: Concentrations and kinetics of renal biomarkers in dogs with gastric dilatation-volvulus with and without 24-h intravenous lidocaine
Publicado: (2023)

Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly
por: Iwanuk, Nayeli, et al.
Publicado: (2019)

Identification of new biophysical markers for pathological ventricular remodelling in tachycardia‐induced dilated cardiomyopathy
por: Benitez‐Amaro, Aleyda, et al.
Publicado: (2018)

Long-term nifekalant use in a patient with dilated cardiomyopathy and recurrent ventricular tachycardia
por: Xiao, Hongyan, et al.
Publicado: (2022)

Effects of tiletamine-zolazepam vs. propofol on peri-induction intraocular pressure in dogs: A randomized, masked crossover study
por: McIver, Katharine A., et al.
Publicado: (2023)

Cell-Free DNA, High-Mobility Group Box-1, and Procalcitonin Concentrations in Dogs With Gastric Dilatation–Volvulus Syndrome
por: Troia, Roberta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g9kc1in4tqhl7hcp402mvmipft